Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis☆

Abstract Objective Accumulating studies indicate that HPV E6/E7 oncoproteins interacting genes, TP53 , BRCA1 and BARD1 , play a critical role in cervical carcinogenesis. We hypothesized that potentially functional polymorphisms in TP53 , BRCA1 and BRAD1 may individually and/or jointly contribute to cervical cancer risk. Methods We genotyped 4 single nucleotide polymorphisms (SNPs) with amino acid changes, TP53 Pro72Arg (rs1042522), BRCA1 Pro871Leu (rs799917), BARD1 Pro24Ser (rs1048108) and Arg378Ser (rs2229571), in a case-control study of 404 cervical cancer cases and 404 cancer-free controls in Chinese women. Results Logistic regression analysis showed that the BRCA1 variant rs799917 TT genotype was associated with a significantly decreased risk of cervical cancer in a recessive genetic model (adjusted OR=0.62, 95% CI=0.40–0.95), compared with the genotypes CT/CC. However, no significant associations with cervical cancer were observed for other 3 SNPs (adjusted OR=1.01, 95% CI=0.68–1.50 for rs1048108 TT vs CT/CC; adjusted OR=1.04, 95% CI=0.67–1.64 for rs2229571 CC vs GG/GC; adjusted OR=0.84, 95% CI=0.59–1.20 for rs1042522 CC vs GG/GC). Conclusion These findings indicate that BRCA1 rs799917 polymorphism may contribute to the risk of cervical cancer in this Chinese population, and further validation in other populations are warranted.